Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Victoria T Potter"'
Autor:
Aimee Jackson, Sylvie D. Freeman, Ann Hunter, Richard Dillon, Victoria T Potter, Georgia Andrew, Jiri Pavlu, Rahuman Salim, Sandeep Nagra, Ram Malladi, Shamyla Siddique, Eleni Tholouli, Rachel Protheroe, Naeem Khan, Keith Wheatley, Keith G. Wilson, Nicholas I. McCarthy, Charles Craddock, Jenny Byrne, Anne Parker, Maria H. Gilleece, Andrea Hodgkinson, Justin Loke, Andrew Peniket, John Mason, Paresh Vyas, Charles Crawley
Publikováno v:
Journal of Clinical Oncology. 39:768-778
PURPOSE Reduced-intensity conditioning (RIC) regimens have extended the curative potential of allogeneic stem-cell transplantation to older adults with high-risk acute myeloid leukemia (AML) and myelodysplasia (MDS) but are associated with a high ris
Autor:
Judith C. W. Marsh, Shreyans Gandhi, Simon Tetlow, Daniele Avenoso, Austin G. Kulasekararaj, Ghulam J. Mufti, Adrian Choy, Victoria T Potter, Pramila Krishnamurthy, Varun Mehra, Antonio Pagliuca, Hugues de Lavallade
Publikováno v:
American Journal of Transplantation. 21:864-869
Classical veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) is a serious complication post allogeneic hematopoietic stem cell transplantation (HSCT). Before the recently revised EBMT criteria, the Baltimore and modified Seattle criteri
Autor:
Tobias Menne, Victoria T Potter, Irfan Kayani, M. Cuadrado, Maria A. V. Marzolini, Maeve A O'Reilly, Wendy Osborne, Piers Em Patten, Reuben Benjamin, Andrea Kuhnl, Nicola Mulholland, Claire Roddie, George Petrides, Amy A Kirkwood, Deborah Yallop, William Townsend, Stefan Vöö, Robin Sanderson
Publikováno v:
Blood Advances
Visual Abstract
Autor:
Ghulam J. Mufti, Victoria T Potter, Shreyans Gandhi, Vipul S Sheth, Donal Mclornan, Antonio Pagliuca, Austin G. Kulasekararaj, K Raj, Varun Mehra, Francesco Dazzi, Hugues de Lavallade, Pramila Krishnamurthy
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 7, Pp 1-6 (2021)
Blood Cancer Journal
Blood Cancer Journal
Pre-emptive DLI (pDLI) is an effective strategy in lowering the risk of relapse without significantly increasing the risk of graft-versus-host disease (GVHD) in the case of T cell lineage mixed chimerism (MC) post allogeneic transplant in hematologic
Autor:
Shafqat Inam, P E M Patten, Orla Stewart, Victoria Metaxa, Malur Sudhanva, Victoria T Potter, Gregory Shields, Kirsty Cuthill, Catherine Hockings, Antonio Pagliuca, Robin Sanderson, Deborah Yallop, Shu Wong, Mili Shah, Andrea Kuhnl, Reuben Benjamin
Publikováno v:
HemaSphere, Vol 5, Iss 3, p e535 (2021)
HemaSphere
HemaSphere
Autor:
Victoria T Potter, T. Pirani, Reuben Benjamin, A. Kuhnl, T. Materski, Victoria Metaxa, M. John, Robin Sanderson
Publikováno v:
Intensive Care Medicine Experimental
Intensive Care Medicine Experimental, Vol 9, Iss 1, Pp 1-2 (2021)
Intensive Care Medicine Experimental, Vol 9, Iss 1, Pp 1-2 (2021)
An amendment to this paper has been published and can be accessed via the original article.
Autor:
J Periselneris, Antonio Pagliuca, M. Mansour Ceesay, Varun Mehra, A Choy, Victoria T Potter, D Avenoso, CG Stovin, P Siriwardena, H. de Lavallade, Pramila Krishnamurthy, A Espehana, V Mallikarjuna
Publikováno v:
Baby and bathwater: not all lung infections are COVID-19.
Invasive fungal lung disease (IFD) is a well-recognised complication post haematopoietic stem-cell transplant (HSCT), occurring in approximately 5–21% of patients, despite tri-azole anti-fungal prophylaxis. Baseline CT thorax (BCT) pre-HSCT is incr
Autor:
Johanna Tischer, Arne Brecht, Tobias Gedde-Dahl, Thomas Valerius, Eolia Brissot, Didier Blaise, Mohamad Mohty, Mohamed A. Kharfan-Dabaja, Bipin N. Savani, Arnon Nagler, Jürgen Kuball, Annalisa Ruggeri, José Luis Díez-Martín, Fabio Benedetti, Tsila Zuckerman, Emanuele Angelucci, Christoph Schmid, Sebastian Giebel, Hélène Labussière-Wallet, Dolores Caballero, Martin Bornhäuser, Jaime Sanz, Victoria T Potter, Ali Bazarbachi, Benedetto Bruno, Myriam Labopin, Fabio Ciceri, Jürgen Finke, Riitta Niittyvuopio
Publikováno v:
BONE MARROW TRANSPLANTATION
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (9), pp.2194-2202. ⟨10.1038/s41409-021-01317-7⟩
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
Bone Marrow Transplantation
Bone Marrow Transplantation, 2021, 56 (9), pp.2194-2202. ⟨10.1038/s41409-021-01317-7⟩
Optimal donor choice for a second allogeneic hematopoietic cell transplant (allo-HCT) in relapsed acute lymphoblastic leukemia (ALL) remains undefined. We compared outcomes using HLA-matched unrelated donors (MUD) versus haploidentical donors in this
Autor:
Bronwen E. Shaw, Adrian Bloor, Chloe Anthias, Rachel Pearce, Daniel J. Weisdorf, Eleni Tholouli, Stephen Mackinnon, Marie C. Wilson, Julia Lee, Kim Orchard, Chrissy h. Roberts, WP Bultitude, Victoria T Potter, Sarah Cooley, Christian A. García-Sepúlveda, Jenny Byrne, Jeffrey S. Miller, Ram Malladi, Neema P. Mayor, Nigel H. Russell, J. Alejandro Madrigal, Steven G.E. Marsh, Richard Szydlo, Michael Potter, Amit Patel, I. Grant McQuaker, Jennifer Schellekens
Publikováno v:
Bone Marrow Transplant
The reported influence of donor Killer-cell Immunoglobulin-like Receptor (KIR) genes on the outcomes of haematopoietic cell transplantation (HCT) are contradictory, in part due to diversity of disease, donor sources, era and conditioning regimens wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77b25c6cbbe121e3fcb012b89141a925
https://researchonline.lshtm.ac.uk/id/eprint/4656314/1/Original_submission_KIR_genotype_in_UK_HCT.pdf
https://researchonline.lshtm.ac.uk/id/eprint/4656314/1/Original_submission_KIR_genotype_in_UK_HCT.pdf
Autor:
Vanesa Anton-Vazquez, Mark Zuckerman, Jean L. Mbisa, Victoria T Potter, Ghulam J. Mufti, Tanya N. Basu, Varun Mehra, Antonio Pagliuca, Marie-Louise Daly, Dan Bradshaw
Publikováno v:
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology. 128
Introduction The emergence of herpes simplex virus (HSV) resistance to aciclovir (ACV) has increasingly been reported among hematopoietic stem cell transplant (HSCT) recipients and often associated with extended ACV prophylaxis. Methods Between June